
    
      The objective of the trial is to demonstrate that the creation of epicardial and endocardial
      lesions with temperature-controlled radiofrequency (TCRF) ablation applied using the Estech
      COBRAÂ® Surgical System during concomitant heart surgery is a safe and effective treatment for
      non-paroxysmal atrial fibrillation (AF).
    
  